Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management

Globally, endometrial cancer is the sixth leading cause of female cancer-related deaths. Non-atypical endometrial hyperplasia (EH), has a lifetime progression rate to endometrial cancer ranging from less than 5%, if simple without atypia, to 40%, if complex with atypia. Site specific, long-acting in...

Descripción completa

Detalles Bibliográficos
Autor principal: Nwanodi, Oroma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618158/
https://www.ncbi.nlm.nih.gov/pubmed/28698465
http://dx.doi.org/10.3390/healthcare5030030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618158/
https://www.ncbi.nlm.nih.gov/pubmed/28698465
http://dx.doi.org/10.3390/healthcare5030030

Ejemplares similares